Works matching IS 18607179 AND DT 2009 AND VI 4 AND IP 2

Results: 26

NG-Acylated Aminothiazolylpropylguanidines as Potent and Selective Histamine H2 Receptor Agonists.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 232, doi. 10.1002/cmdc.200800296

By:

Kraus, Anja;
Ghorai, Prasanta;
Birnkammer, Tobias;
Schnell, David;
Elz, Sigurd;
Seifert, Roland;
Dove, Stefan;
Bernhardt, Günther;
Buschauer, Armin

Publication type:

Article

Preview: ChemMedChem 3/2009.

Published in:: ChemMedChem, 2009, v. 4, n. 2, p. 295, doi. 10.1002/cmdc.200990009
Publication type:: Article

Toward Docking-Based Virtual Screening for Discovering Antitubulin Agents by Targeting Taxane and Colchicine Binding Sites.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 161, doi. 10.1002/cmdc.200800319

By:

Soulère, Laurent

Publication type:

Article

In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42-Binding D-Enantiomeric Peptides in Transgenic AD Mouse Models.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 276, doi. 10.1002/cmdc.200800289

By:

van Groen, Thomas;
Kadish, Inga;
Wiesehan, Katja;
Funke, Susanne A.;
Willbold, Dieter

Publication type:

Article

Essential Concepts in Toxicogenomics (Methods in Molecular Biology Series) . Edited by Donna L. Mendrick and William B. Mattes.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 292, doi. 10.1002/cmdc.200800406

By:

Kimber, Ian

Publication type:

Article

Functional Proteomics on Zinc-Dependent Metalloproteinases using Inhibitor Probes.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 164, doi. 10.1002/cmdc.200800284

By:

Klein, Theo;
P. Geurink, Paul;
S. Overkleeft, Hermen;
K. Kauffman, Henk;
Bischoff, Rainer

Publication type:

Article

Nonglycosidic Agonists of Invariant NKT Cells for Use as Vaccine Adjuvants.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 171, doi. 10.1002/cmdc.200800354

By:

Reddy, B. Gopal;
Silk, Jonathan D.;
Salio, Mariolina;
Balamurugan, Rengarajan;
Shepherd, Dawn;
Ritter, Gerd;
Cerundolo, Vincenzo;
Schmidt, Richard R.

Publication type:

Article

Natural Compounds as Drugs, Volumes I and II. Edited by Frank Petersen and René Amstutz.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 291, doi. 10.1002/cmdc.200800394

By:

Britton, Robert A.

Publication type:

Article

Structure-Activity Relationship Analysis of the Peptide Deformylase Inhibitor 5-Bromo-1 H-indole-3-acetohydroxamic Acid.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 261, doi. 10.1002/cmdc.200800251

By:

Petit, Sylvain;
Duroc, Yann;
Larue, Valéry;
Giglione, Carmela;
Léon, Carole;
Soulama, Coralie;
Denis, Alexis;
Dardel, Frédéric;
Meinnel, Thierry;
Artaud, Isabelle

Publication type:

Article

Spotlights on our sister journals: ChemMedChem 2/2009.

Published in:: ChemMedChem, 2009, v. 4, n. 2, p. 144, doi. 10.1002/cmdc.200990008
Publication type:: Article

Cover Picture: Structure-Activity Relationship Analysis of the Peptide Deformylase Inhibitor 5-Bromo-1 H-indole-3-acetohydroxamic Acid (ChemMedChem 2/2009).

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 133, doi. 10.1002/cmdc.200990004

By:

Petit, Sylvain;
Duroc, Yann;
Larue, Valéry;
Giglione, Carmela;
Léon, Carole;
Soulama, Coralie;
Denis, Alexis;
Dardel, Frédéric;
Meinnel, Thierry;
Artaud, Isabelle

Publication type:

Article

Multi-Drug-Resistance-Reverting Agents: 2-Aryloxazole and 2-Arylthiazole Derivatives as Potent BCRP or MRP1 Inhibitors.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 188, doi. 10.1002/cmdc.200800329

By:

Colabufo, Nicola A.;
Berardi, Francesco;
Perrone, Maria Grazia;
Cantore, Mariangela;
Contino, Marialessandra;
Inglese, Carmela;
Niso, Mauro;
Perrone, Roberto

Publication type:

Article

Pyridylalanine-Containing Hydroxamic Acids as Selective HDAC6 Inhibitors.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 283, doi. 10.1002/cmdc.200800196

By:

Schäfer, Stefan;
Saunders, Laura;
Schlimme, Sonja;
Valkov, Vassil;
Wagner, Julia M.;
Kratz, Felix;
Sippl, Wolfgang;
Verdin, Eric;
Jung, Manfred

Publication type:

Article

Similarity-Based Virtual Screening with a Bayesian Inference Network.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 210, doi. 10.1002/cmdc.200800290

By:

Abdo, Ammar;
Salim, Naomie

Publication type:

Article

Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 241, doi. 10.1002/cmdc.200800261

By:

Freundlich, Joel S.;
Wang, Feng;
Vilchèze, Catherine;
Gulten, Gulcin;
Langley, Robert;
Schiehser, Guy A.;
Jacobus, David P.;
Jacobs, William R.;
Sacchettini, James C.

Publication type:

Article

Inhibition of hERG Channel Trafficking: An Under-Explored Mechanism for Drug-Induced QT Prolongation.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 141, doi. 10.1002/cmdc.200990007

By:

Yeung, Kap-Sun;
Meanwell, Nicholas A.

Publication type:

Article

Development and Validation of a Pharmacophore-Based QSAR Model for the Prediction of CNS Activity.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 204, doi. 10.1002/cmdc.200800282

By:

Gozalbes, Rafael;
Barbosa, Frédérique;
Nicolaï, Eric;
Horvath, Dragos;
Froloff, Nicolas

Publication type:

Article

Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 219, doi. 10.1002/cmdc.200800334

By:

Feng, Xiao-Qing;
Liang, Yong-Hong;
Zeng, Zhao-Sen;
Chen, Fen-Er;
Balzarini, Jan;
Pannecouque, Christophe;
De Clercq, Erik

Publication type:

Article

Synthesis of Bicyclic N-Arylmethyl-Substituted Iminoribitol Derivatives as Selective Nucleoside Hydrolase Inhibitors.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 249, doi. 10.1002/cmdc.200800231

By:

Berg, Maya;
Bal, Gunther;
Goeminne, Annelies;
Van der Veken, Pieter;
Versées, Wim;
Steyaert, Jan;
Haemers, Achiel;
Augustyns, Koen

Publication type:

Article

New Antibiotic Targets. Edited by W. Scott Champley.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 292, doi. 10.1002/cmdc.200800419

By:

Zabriskie, Mark

Publication type:

Article

Graphical Abstract: ChemMedChem 2/2009.

Published in:: ChemMedChem, 2009, v. 4, n. 2, p. 135, doi. 10.1002/cmdc.200990006
Publication type:: Article

(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 196, doi. 10.1002/cmdc.200800276

By:

Franchini, Silvia;
Tait, Annalisa;
Prandi, Adolfo;
Sorbi, Claudia;
Gallesi, Rossella;
Buccioni, Michela;
Marucci, Gabriella;
De Stefani, Carla;
Cilia, Antonio;
Brasili, Livio

Publication type:

Article

Tritium-Labeled N1-[3-(1 H-imidazol-4-yl)propyl]- N2-propionylguanidine ([3H]UR-PI294), a High-Affinity Histamine H3 and H4 Receptor Radioligand.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 225, doi. 10.1002/cmdc.200800349

By:

Igel, Patrick;
Schnell, David;
Bernhardt, Günther;
Seifert, Roland;
Buschauer, Armin

Publication type:

Article

Peptides and Peptide Mimics as Modulators of Apoptotic Pathways.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 146, doi. 10.1002/cmdc.200800246

By:

Orzáez, Mar;
Gortat, Anna;
Mondragón, Laura;
Pérez-Payá, Enrique

Publication type:

Article

Cytotoxic Rhodium(III) and Iridium(III) Polypyridyl Complexes: Structure-Activity Relationships, Antileukemic Activity, and Apoptosis Induction.

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 177, doi. 10.1002/cmdc.200800311

By:

Dobroschke, Mara;
Geldmacher, Yvonne;
Ott, Ingo;
Harlos, Melanie;
Kater, Lisa;
Wagner, Laura;
Gust, Ronald;
Sheldrick, William S.;
Prokop, Aram

Publication type:

Article

Inside Cover: Tritium-Labeled N1-[3-(1 H-imidazol-4-yl)propyl]- N2-propionylguanidine ([3H]UR-PI294), a High-Affinity Histamine H3 and H4 Receptor Radioligand / NG-Acylated Aminothiazolylpropylguanidines as Potent and Selective Histamine H2 Receptor Agonists (ChemMedChem 2/2009)

Published in:

ChemMedChem, 2009, v. 4, n. 2, p. 134, doi. 10.1002/cmdc.200990005

By:

Igel, Patrick;
Schnell, David;
Bernhardt, Günther;
Seifert, Roland;
Buschauer, Armin;
Kraus, Anja;
Ghorai, Prasanta;
Birnkammer, Tobias;
Elz, Sigurd;
Dove, Stefan

Publication type:

Article

Works matching IS 18607179 AND DT 2009 AND VI 4 AND IP 2

N<sup>G</sup>-Acylated Aminothiazolylpropylguanidines as Potent and Selective Histamine H<sub>2</sub> Receptor Agonists.

Preview: ChemMedChem 3/2009.

Toward Docking-Based Virtual Screening for Discovering Antitubulin Agents by Targeting Taxane and Colchicine Binding Sites.

In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42-Binding D-Enantiomeric Peptides in Transgenic AD Mouse Models.

Essential Concepts in Toxicogenomics (Methods in Molecular Biology Series) . Edited by Donna L. Mendrick and William B. Mattes.

Functional Proteomics on Zinc-Dependent Metalloproteinases using Inhibitor Probes.

Nonglycosidic Agonists of Invariant NKT Cells for Use as Vaccine Adjuvants.

Natural Compounds as Drugs, Volumes I and II. Edited by Frank Petersen and René Amstutz.

Structure-Activity Relationship Analysis of the Peptide Deformylase Inhibitor 5-Bromo-1 H-indole-3-acetohydroxamic Acid.

Spotlights on our sister journals: ChemMedChem 2/2009.

Cover Picture: Structure-Activity Relationship Analysis of the Peptide Deformylase Inhibitor 5-Bromo-1 H-indole-3-acetohydroxamic Acid (ChemMedChem 2/2009).

Multi-Drug-Resistance-Reverting Agents: 2-Aryloxazole and 2-Arylthiazole Derivatives as Potent BCRP or MRP1 Inhibitors.

Pyridylalanine-Containing Hydroxamic Acids as Selective HDAC6 Inhibitors.

Similarity-Based Virtual Screening with a Bayesian Inference Network.

Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.

Inhibition of hERG Channel Trafficking: An Under-Explored Mechanism for Drug-Induced QT Prolongation.

Development and Validation of a Pharmacophore-Based QSAR Model for the Prediction of CNS Activity.

Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity.

Synthesis of Bicyclic N-Arylmethyl-Substituted Iminoribitol Derivatives as Selective Nucleoside Hydrolase Inhibitors.

New Antibiotic Targets. Edited by W. Scott Champley.

Graphical Abstract: ChemMedChem 2/2009.

(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT<sub>1A</sub> Receptor Agonist.

Tritium-Labeled N<sup>1</sup>-[3-(1 H-imidazol-4-yl)propyl]- N<sup>2</sup>-propionylguanidine ([<sup>3</sup>H]UR-PI294), a High-Affinity Histamine H<sub>3</sub> and H<sub>4</sub> Receptor Radioligand.

Peptides and Peptide Mimics as Modulators of Apoptotic Pathways.

Cytotoxic Rhodium(III) and Iridium(III) Polypyridyl Complexes: Structure-Activity Relationships, Antileukemic Activity, and Apoptosis Induction.